Search
for
Sort by
Research 331–360 of 410
- Ruxolitinib found to cause eyelash growth: a case report
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Does Severity of Hair Loss Matter? Factors Associated with Mental Health Outcomes in Women Irradiated for Tinea Capitis in Childhood
- Patient-reported outcome assessment and objective evaluation of chemotherapy-induced alopecia
- Survey on adverse events associated with drug therapy for breast cancer patients
- Beyond DNA-targeting in Cancer Chemotherapy. Emerging Frontiers - A Review
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Sorafenib stimulates human skin type mast cell degranulation and maturation
- Improving Quality of Life During Chemotherapy: Cannabinoids, Cryotherapy, and Scalp Cooling
- Therapeutic Effect of Superficial Scalp Hypothermia on Chemotherapy-Induced Alopecia in Breast Cancer Survivors
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Prevention of chemotherapy drug-mediated human hair follicle damage: combined use of cooling with antioxidant suppresses oxidative stress and prevents matrix keratinocyte cytotoxicity
- Atypical and giant proliferating pilomatrixoma of the eyelid: a clinicopathological report
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early‐stage breast cancer—The COOL study
- The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
- Clinical Pathobiology of Radiotherapy-Induced Alopecia: A Guide toward More Effective Prevention and Hair Follicle Repair
- ER71/ETV2 Promotes Hair Regeneration from Chemotherapeutic Drug-Induced Hair Loss by Enhancing Angiogenesis
- Hypertrichosis, trichomegaly, and androgenic alopecia related to cetuximab treatment
- Impact of a topical lotion, CG428, on permanent chemotherapy-induced alopecia in breast cancer survivors: a pilot randomized double-blind controlled clinical trial (VOLUME RCT)
- Treatment of Cultured Sebocytes with an EGFR Inhibitor Does Not Lead to Significant Upregulation of Inflammatory Biomarkers
- Safety assessment of cyclin-dependent kinase 4/6 inhibitors and comparison of time to adverse events
- Selective androgen receptor modulators: a critical appraisal
- A disproportionality analysis of adverse events caused by pexidartinib from the FDA adverse event reporting system
- Dermatologic Adverse Events from Cancer Treatments
- Sexual Dysfunction in Alopecia Areata: A Systematic Review
- Optimizing hair care products and practices for Black patients with breast cancer: One size does not fit all
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Primary vitreoretinal lymphoma masquerading as refractory uveitis—just go with the flow
- Novel Synergistic Approach for Bioactive Macromolecules: Evaluating the Efficacy of Goat Placenta Extract in PEGylated Liposomes and Microspicules for Chemotherapy-Induced Hair Loss